T. Rowe Price Associates

T. Rowe Price Associates’s Ocera Therapeutics, Inc. OCRX Stock Holding History

T. Rowe Price Associates’s Portfolio OCRX Stock Details OCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell
2014 Q4	$203K	Sell
2014 Q3	$159K	Hold
2014 Q2	$248K	Sell
2014 Q1	$821K	Buy